Miguel E. Rentería: At the intersection of genomics, neuroscience, and big data

Dr Miguel E. Rentería illuminates our understanding of brain disorders through groundbreaking computational neurogenomics research that promises personalized treatments for millions worldwide. This inspiring Genomic Press Interview reveals how a curious child from Mexico who “asked too many questions” became a world-leading scientist at QIMR Berghofer Medical Research Institute, where he masterfully combines genomics, neuroscience, and cutting-edge data science to unlock the mysteries of Parkinson's disease and psychiatric conditions. With over 120 publications in prestigious journals, including Nature and Nature Genetics, garnering more than 10,000 citations, Rentería stands as a beacon of scientific excellence and global collaboration. His visionary leadership of the Australian Parkinson's Genetics Study, now encompassing nearly 20,000 volunteers nationwide, represents the largest cohort of its kind in Australia and exemplifies his commitment to building transformative research resources. As Co-Chair of ENIGMA's working group on Suicidal Thoughts and Behaviours and founding member of PGC's Suicide Genetics group, he drives international efforts to understand the most complex brain conditions. His pioneering integration of wearable sensors with genomic data creates unprecedented opportunities for precision medicine. At the same time, his passionate advocacy for global equity ensures genetic research benefits all populations, not just those of European ancestry. Honoured with the 2024 Adèle Green Emerging Research Leadership Award, the prestigious Al & Val Rosenstrauss Fellowship, and recognition as an Atlantic Fellow at the Global Brain Health Institute, Rentería continues to inspire through his determination to transform how we diagnose, monitor, and treat brain disorders, driven by the philosophy of carpe diem and an unwavering belief that science should be for everyone.